Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / 2022 - Page 11

Year: 2022

USDA confirmed highly pathogenic Avian influenza in New Jersey
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza

USDA confirmed highly pathogenic Avian influenza in New Jersey

On May 18, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…

Read More USDA confirmed highly pathogenic Avian influenza in New JerseyContinue

Labcorp received EUA for first non-prescription at-home collection kit for combined COVID-19, Fflu and RSV detection
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza

Labcorp received EUA for first non-prescription at-home collection kit for combined COVID-19, Fflu and RSV detection

On May 18, 2022, LabCorp announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and…

Read More Labcorp received EUA for first non-prescription at-home collection kit for combined COVID-19, Fflu and RSV detectionContinue

CDC and health partners responded to Monkeypox case in the U.S.
Biotechnology | CDC | Infectious Disease | Vaccine

CDC and health partners responded to Monkeypox case in the U.S.

On May 18, 2022, scientists at the Centers for Disease Control and Prevention (CDC) announced that they were…

Read More CDC and health partners responded to Monkeypox case in the U.S.Continue

Study found モnatural immunityヤ from Omicron weak and limited
Life Science History

Study found モnatural immunityヤ from Omicron weak and limited

On May 18, 2022, researchers at Gladstone Institutes and UC San Francisco (UCSF) reported that unvaccinated people, infection…

Read More Study found モnatural immunityヤ from Omicron weak and limitedContinue

InteliSwabᆴ COVID-19 rapid test validated to detect Omicron BA.2, BA.2.12.1, BA.3 and BA.5 subvariants
COVID-19 | Life Science History

InteliSwabᆴ COVID-19 rapid test validated to detect Omicron BA.2, BA.2.12.1, BA.3 and BA.5 subvariants

On May 17, 2022, OraSure Technologies announced that its InteliSwabᆴ COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1,…

Read More InteliSwabᆴ COVID-19 rapid test validated to detect Omicron BA.2, BA.2.12.1, BA.3 and BA.5 subvariantsContinue

Pfizer and BioNTech granted U.S. EUA for booster dose of COVID-19 vaccine in children 5 through 11 years of age
COVID-19 | Life Science History

Pfizer and BioNTech granted U.S. EUA for booster dose of COVID-19 vaccine in children 5 through 11 years of age

On May 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration expanded emergency use authorization…

Read More Pfizer and BioNTech granted U.S. EUA for booster dose of COVID-19 vaccine in children 5 through 11 years of ageContinue

TGen worked with Arizona zoos and state and federal wildlife agencies to test wild animals for SARS-CoV-2
COVID-19 | Life Science History

TGen worked with Arizona zoos and state and federal wildlife agencies to test wild animals for SARS-CoV-2

On May 16, 2022, working with state and federal wildlife agencies and private and public zoos across Arizona,…

Read More TGen worked with Arizona zoos and state and federal wildlife agencies to test wild animals for SARS-CoV-2Continue

Tabula Sapiens multiple-organ, single-cell transcriptomic atlas of humans published
Biotechnology | Genomics

Tabula Sapiens multiple-organ, single-cell transcriptomic atlas of humans published

On May 13, 2022, the Tabula Sapiens Consortium announced it had published a molecular reference atlas for more…

Read More Tabula Sapiens multiple-organ, single-cell transcriptomic atlas of humans publishedContinue

Novavax filed for Emergency Use Authorization of COVID-19 vaccine in Taiwan
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax filed for Emergency Use Authorization of COVID-19 vaccine in Taiwan

On May 13, 2022, Novavax announced the submission of a request for emergency use authorization to Taiwan’s Food…

Read More Novavax filed for Emergency Use Authorization of COVID-19 vaccine in TaiwanContinue

WHO and Medicines Patent Pool announced agreement with NIH for COVID-19 health technologies
COVID-19 | Life Science History | Vaccine | WHO

WHO and Medicines Patent Pool announced agreement with NIH for COVID-19 health technologies

On May 12, 2022, WHOメs COVID-19 Technology Access Pool and the Medicines Patent Pool finalized a licensing agreement…

Read More WHO and Medicines Patent Pool announced agreement with NIH for COVID-19 health technologiesContinue

Cepheid received Emergency Use Authorization for Xpertᆴ Xpress CoV-2 plus
COVID-19 | Life Science History

Cepheid received Emergency Use Authorization for Xpertᆴ Xpress CoV-2 plus

On May 12, 2022, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…

Read More Cepheid received Emergency Use Authorization for Xpertᆴ Xpress CoV-2 plusContinue

NIH licensed COVID-19 research tools and early-stage technologies to WHO program
COVID-19 | Life Science History | Vaccine

NIH licensed COVID-19 research tools and early-stage technologies to WHO program

On May 12, 2022, the U.S. National Institutes of Health announced that it had licensed 11 COVID-19 research…

Read More NIH licensed COVID-19 research tools and early-stage technologies to WHO programContinue

Lucira filed for authorization of first-of-its-Kind COVID-19 & flu at-home molecular test
COVID-19 | Life Science History

Lucira filed for authorization of first-of-its-Kind COVID-19 & flu at-home molecular test

On May 11, 2022, Lucira Health announced that it had submitted a request to the U.S. Food and…

Read More Lucira filed for authorization of first-of-its-Kind COVID-19 & flu at-home molecular testContinue

KPWHRI report supported value of COVID-19 drugs
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research | Therapeutics

KPWHRI report supported value of COVID-19 drugs

On May 11, 2022, Kaiser Permanente Washington Health Research Institute reported that new treatments for people at high…

Read More KPWHRI report supported value of COVID-19 drugsContinue

Lucira received CE Mark for both COVID-19 & flu and COVID-19 molecular tests
COVID-19 | Life Science History

Lucira received CE Mark for both COVID-19 & flu and COVID-19 molecular tests

On May 9, 2022, Lucira Health announced that both its COVID-19 & Flu and COVID-19 molecular tests have…

Read More Lucira received CE Mark for both COVID-19 & flu and COVID-19 molecular testsContinue

WHO informed of a confirmed case of monkeypox in an individual who travelled from the United Kingdom to Nigeria
Life Science History | WHO

WHO informed of a confirmed case of monkeypox in an individual who travelled from the United Kingdom to Nigeria

On May 7, 2022, WHO was informed of a confirmed case of monkeypox in an individual who travelled…

Read More WHO informed of a confirmed case of monkeypox in an individual who travelled from the United Kingdom to NigeriaContinue

Novavax submitted variations to expand Australian and New Zealand provisional approval of Nuvaxovid COVID-19 vaccine in Great Britain
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax submitted variations to expand Australian and New Zealand provisional approval of Nuvaxovid COVID-19 vaccine in Great Britain

On May 6, 2022, Novavax announced the submission of variations to the Australian Therapeutic Goods Agency (TGA) and…

Read More Novavax submitted variations to expand Australian and New Zealand provisional approval of Nuvaxovid COVID-19 vaccine in Great BritainContinue

NIH launched clinical trial of Epstein-Barr virus vaccine
Life Science History | NIH | Vaccine

NIH launched clinical trial of Epstein-Barr virus vaccine

On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…

Read More NIH launched clinical trial of Epstein-Barr virus vaccineContinue

Highly pathogenic Avian influenza detected in a non-commercial backyard flock in Oregon
Agriculture | Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | USDA | Veterinary

Highly pathogenic Avian influenza detected in a non-commercial backyard flock in Oregon

On May 6, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) confirmed the…

Read More Highly pathogenic Avian influenza detected in a non-commercial backyard flock in OregonContinue

Novavax’s COVID-19 vaccine Nuvaxovid arrived in Singapore
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax’s COVID-19 vaccine Nuvaxovid arrived in Singapore

On May 6, 2022, Novavax announced that deliveries of it’s COVID-19 vaccine continued around the world and the…

Read More Novavax’s COVID-19 vaccine Nuvaxovid arrived in SingaporeContinue

WHO reported 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021
COVID-19 | Life Science History | WHO

WHO reported 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021

On May 5, 2022, the World Health Organization (WHO) reported estimates that show the full death toll associated…

Read More WHO reported 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021Continue

U.S. EPA and State of Florida approved second pilot project with Oxitec Friendlyル mosquitoes in the Florida Keys
Agriculture | Life Science History

U.S. EPA and State of Florida approved second pilot project with Oxitec Friendlyル mosquitoes in the Florida Keys

On May 4, 2022, Oxitec announced approval from the Florida Department of Agriculture and Consumer Services, including reviews…

Read More U.S. EPA and State of Florida approved second pilot project with Oxitec Friendlyル mosquitoes in the Florida KeysContinue

Sorrento announced full enrollment of phase I study of intranasal STI-9199 (COVISHIELD) against Omicron BA.2 and all variants of concern
Biotechnology | COVID-19

Sorrento announced full enrollment of phase I study of intranasal STI-9199 (COVISHIELD) against Omicron BA.2 and all variants of concern

On May 2, 2022, Sorrento announced its Phase I study of intranasal STI-9199 (COVISHIELDTM) had been fully enrolled…

Read More Sorrento announced full enrollment of phase I study of intranasal STI-9199 (COVISHIELD) against Omicron BA.2 and all variants of concernContinue

USDA confirmed highly pathogenic Avian influenza in Oklahoma
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA

USDA confirmed highly pathogenic Avian influenza in Oklahoma

On May 1, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service confirmed the presence…

Read More USDA confirmed highly pathogenic Avian influenza in OklahomaContinue

USDA confirmed highly pathogenic Avian influenza in Alaska
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Veterinary

USDA confirmed highly pathogenic Avian influenza in Alaska

On Apr. 30, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…

Read More USDA confirmed highly pathogenic Avian influenza in AlaskaContinue

USDA confirmed highly pathogenic Avian influenza in Vermont
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza

USDA confirmed highly pathogenic Avian influenza in Vermont

On Apr. 29, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…

Read More USDA confirmed highly pathogenic Avian influenza in VermontContinue

Moderna finalized plan for long-term strategic partnership with the Government of Canada
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna finalized plan for long-term strategic partnership with the Government of Canada

On Apr. 29, 2022, Moderna announced its plan to build a state-of-the-art mRNA vaccine manufacturing facility in Quebec…

Read More Moderna finalized plan for long-term strategic partnership with the Government of CanadaContinue

Moderna filed to expand conditional Marketing Authorization for COVID-19 vaccine to include children six months to under six years in the EU
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna filed to expand conditional Marketing Authorization for COVID-19 vaccine to include children six months to under six years in the EU

On Apr. 29, 2022, Moderna announced that it had submitted for a variation to the conditional marketing authorization…

Read More Moderna filed to expand conditional Marketing Authorization for COVID-19 vaccine to include children six months to under six years in the EUContinue

Moderna filed for authorization of Its COVID-19 vaccine in young children six months to under six years of age
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna filed for authorization of Its COVID-19 vaccine in young children six months to under six years of age

On Apr. 28, 2022, Moderna announced that it had submitted a request for emergency use authorization (EUA) for…

Read More Moderna filed for authorization of Its COVID-19 vaccine in young children six months to under six years of ageContinue

Disease | Therapeutics | WHO

WHO reported Ebola virus disease in Democratic Republic of the Congo

On Apr. 28, 2022, the Ministry of Health of the Democratic Republic of the Congo declared an outbreak…

Read More WHO reported Ebola virus disease in Democratic Republic of the CongoContinue

Page navigation

Previous PagePrevious 1 … 9 10 11 12 13 … 19 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search